In some developed countries, H. pylori IgG, pepsinogens (PGs), and gastrin-17 (G-17) have been studied as non-invasive serological evaluation of gastric cancer and precancerous gastric lesions and have been suggested a variety of cut-off values [8–11]. Here, GAST is linked to gastric cancer.